Mainz Biomed (NASDAQ:MYNZ – Get Rating) – Analysts at HC Wainwright boosted their Q2 2023 earnings per share (EPS) estimates for Mainz Biomed in a note issued to investors on Tuesday, May 16th. HC Wainwright analyst Y. Chen now expects that the company will post earnings per share of ($0.44) for the quarter, up from […]